Related references
Note: Only part of the references are listed.RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
Irah L. King et al.
BLOOD (2009)
Quinpramine is a novel compound effective in ameliorating brain autoimmune disease
Mahendra P. Singh et al.
EXPERIMENTAL NEUROLOGY (2009)
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yuhong Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
Wei Hu et al.
PLOS ONE (2009)
Tracing Functional Antigen-Specific CCR6+ Th17 Cells after Vaccination
Johann Poetzl et al.
PLOS ONE (2008)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
T-bet is essential for the progression of experimental autoimmune encephalomyelitis
Narender Nath et al.
IMMUNOLOGY (2006)
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity
O Stüve et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Passive induction of experimental allergic encephalomyelitis
Ingunn M. Stromnes et al.
NATURE PROTOCOLS (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
M Greter et al.
NATURE MEDICINE (2005)
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis
E Bettelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes
AE Lovett-Racke et al.
IMMUNITY (2004)
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
S Youssef et al.
NATURE (2002)
Share Paper
